Paris, France

Elisabeth Laugier-Laglenne

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 2004-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovative Contributions of Elisabeth Laugier-Laglenne in Aesthetic Medicine

Introduction

Elisabeth Laugier-Laglenne, a notable inventor based in Paris, France, has made significant strides in the field of aesthetic medicine. With two patents to her name, she demonstrates a commitment to enhancing medical techniques that improve both health and beauty.

Latest Patents

One of her latest innovations is an implant designed for subcutaneous or intradermal injection. This invention specifically targets filling up wrinkles, thin lines, skin cracks, and scars, which is particularly beneficial for reparative or plastic surgery and aesthetic dermatology. The implant also finds applications in dental treatments for filling gums.

The innovation utilizes biologically absorbable polymer microspheres or microparticles suspended in a gel. This gel can either be produced as a ready-to-use product or freeze-dried. A noteworthy aspect of this invention is the controlled biological absorbability of the microspheres, allowing for the production of implants with precise persistence, deliberately limited to three years.

Career Highlights

Elisabeth works for Aventis Pharmaceuticals Holdings, Inc., a company recognized for its contributions to pharmaceutical sciences. Her inventive spirit and scientific knowledge have positioned her as a key figure in advancing injectable therapies.

Collaborations

Throughout her career, Elisabeth has collaborated with esteemed professionals in her field, including Hatem Fessi and Franck Gouchet. These collaborations highlight her ability to work within a team to bring innovative medical solutions to fruition.

Conclusion

Elisabeth Laugier-Laglenne exemplifies the innovative spirit that drives advancements in the medical industry. Her dedication to developing effective and biologically compatible solutions serves the dual purpose of enhancing aesthetic outcomes while ensuring patient safety. As she continues her work at Aventis Pharmaceuticals, her contributions are likely to influence both current practices and future innovations in aesthetic medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…